On August, 28, 2024, Aimed Alliance received an interim response from the Food and Drug Administration regarding its Citizen Petition on alternative funding programs (AFPs) and their use of international importation. On March 27, 2026, the FDA provides a complete response to Aimed Alliance’s petition stating that (1) AFPs are not permissible under FD&C Act Section 804 and (2) when determining if it is permissible for a consumer to import their prescription drug from outside the United States, FDA does not consider cost as part of its analysis. Read FDA’s full response to Aimed Alliance’s Citizen Petition..
Last Updated on March 27, 2026 by Aimed Alliance
